Autism Spectrum Disorder (ASDNCT06850948
Experiences of Healthcare for Autistic TGD Adults
An observational study of Autism Spectrum Disorder (ASD, run by University of Nottingham at 1 site in United Kingdom.
Trial summary
To explore the experiences of autistic gender diverse adults that have attempted or are attempting to access, have accessed or are currently accessing gender identity healthcare in the United Kingdom Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Autism Spectrum Disorder (ASD
- What is being tested?
- Qualitative
- How many people
- 13 participants
- Where
- 1 siteUnited Kingdom
- Study dates
- 22 Jul 2025to 28 Sep 2026
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: The present study will be promoted via the NHS at the Nottingham Centre for Transgender Health, for which advertisements of the study (see attached document) will be displayed within the clinic
Who may be able to join
- 18 years or older
- Experience of accessing a NHS Gender identity clinics in the United Kingdom
- Identify as transgender and/or gender diverse
- Have a clinical diagnosis of autism
- Communicate in the English Language
- Be able to provide informed consent
Who cannot join
- People who do not meet the inclusion criteria
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Exploring the Experiences of Gender Identity Healthcare for Autistic Transgender/ Gender Diverse Adults
To explore the experiences of autistic gender diverse adults that have attempted or are attempting to access, have accessed or are currently accessing gender identity healthcare in the United Kingdom
- Conditions
- Autism Spectrum Disorder (ASD
- Being tested
- Qualitative
- Medical subject headings
- Autism Spectrum Disorder
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
QualitativeOther
Interviews collected with participants concerning their experience of gender identity healthcare
What is being measured
The primary outcome is the main question the study is designed to answer.
Interview
Qualitative interview
Measured: From March 2025 to September 2026
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted28 Feb 2025
- Study start22 Jul 2025
- Primary completion11 Sep 2026
- Study completion28 Sep 2026
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Autism Spectrum Disorder (ASDStudies of the same condition, open and under way.
- More trials run by University of NottinghamThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Other
- Enrolment
- 13 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Nottingham
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06850948
- Sponsor's protocol ID
- 25003
- Status last verified
- Sep 2026
- First submitted
- 26 Feb 2025
- Last updated
- 2 Oct 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 2 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Exploring the Experiences of Gender Identity Healthcare for Autistic Transgender/ Gender Diverse Adults
- ClinicalTrials.gov ID
- NCT06850948
- Acronym / sponsor ID
- 25003
- Conditions
- Autism Spectrum Disorder (ASD
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 13 participants (actual)
- Lead sponsor
- University of NottinghamUniversity, hospital or other
- Study start
- 22 Jul 2025 (actual)
- Primary completion
- 11 Sep 2026 (actual)
- Study completion
- 28 Sep 2026 (actual)
- First posted
- 28 Feb 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
To explore the experiences of autistic gender diverse adults that have attempted or are attempting to access, have accessed or are currently accessing gender identity healthcare in the United Kingdom
Study design
- Observational model
- Other
- Time perspective
- Other
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- The present study will be promoted via the NHS at the Nottingham Centre for Transgender Health, for which advertisements of the study (see attached document) will be displayed within the clinic
Key inclusion criteria (6 listed)
- 18 years or older
- Experience of accessing a NHS Gender identity clinics in the United Kingdom
- Identify as transgender and/or gender diverse
- Have a clinical diagnosis of autism
- Communicate in the English Language
Key exclusion criteria (1 listed)
- People who do not meet the inclusion criteria
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| QualitativeInterviews collected with participants concerning their experience of gender identity healthcare | Other | – |
Primary outcome
Interview
Time frame: From March 2025 to September 2026
Qualitative interview
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 2 Oct 2026.
- Individual participant dataSharing planned: Undecided
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Autism Spectrum Disorder (ASD, run by University of Nottingham at 1 site in United Kingdom.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 2 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Interview (time frame: From March 2025 to September 2026). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Oct 2026.